当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:271.42亿  总市值:279.09亿
流通股本:14.56亿   总股本:14.97亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,294,859,508.89,035,678,576.677,196,987,820.314,852,811,188.72
收到的税费返还14,498,857.71240,360,732.18183,390,907.225,959,218.1
收到其他与经营活动有关的现金30,640,225.51291,206,417.02225,826,912.79178,674,611.92
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,339,998,592.029,567,245,725.877,606,205,640.35,057,445,018.74
购买商品、接受劳务支付的现金770,594,306.262,333,664,987.552,269,316,191.631,405,350,291.73
支付给职工以及为职工支付的现金531,009,002.341,664,807,572.341,257,345,619.29843,572,887.25
支付的各项税费242,961,786.49808,671,410.35660,225,730.5479,322,119.35
支付其他与经营活动有关的现金600,325,838.072,587,437,831.821,541,934,311.751,031,372,206.61
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,144,890,933.167,394,581,802.065,728,821,853.173,759,617,504.94
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额195,107,658.862,172,663,923.811,877,383,787.131,297,827,513.8
二、投资活动产生的现金流量:
收回投资收到的现金-6,050,627.356,030,415.646,030,415.64
取得投资收益收到的现金34,013.7462,253.22428,801.16428,801.16
处置固定资产、无形资产和其他长期资产收回的现金净额33,0005,197,349.522,589,148.231,600,006.8
收到的其他与投资活动有关的现金20,000,00020,000,000--
投资活动现金流入的平衡项目0000
投资活动现金流入小计20,067,013.731,710,230.099,048,365.038,059,223.6
购建固定资产、无形资产和其他长期资产支付的现金385,576,040.731,853,335,193.381,134,279,640.18788,970,589.8
投资支付的现金21,500,00078,620,923.7460,026,473.7434,500,000
支付其他与投资活动有关的现金45,150,00020,030,135.1830,135.18-
投资活动现金流出的平衡项目0000
投资活动现金流出小计452,226,040.731,951,986,252.31,194,336,249.1823,470,589.8
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-432,159,027.03-1,920,276,022.21-1,185,287,884.07-815,411,366.2
三、筹资活动产生的现金流量:
吸收投资收到的现金591,515,088.97---
取得借款收到的现金945,986,9806,201,877,6104,012,608,0102,986,057,600
收到其他与筹资活动有关的现金200,000,000---
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,737,502,068.976,201,877,6104,012,608,0102,986,057,600
偿还债务支付的现金740,040,0005,615,552,349.843,983,809,3002,977,445,100
分配股利、利润或偿付利息支付的现金35,494,312.1506,835,414.5428,305,808.96103,814,180.9
其中:子公司支付给少数股东的股利、利润-31,470,802.511,870,802.511,870,802.5
支付其他与筹资活动有关的现金6,339,157.78212,401,911.93206,704,634.3201,804,882.02
筹资活动现金流出平衡项目0000
筹资活动现金流出小计781,873,469.886,334,789,676.274,618,819,743.263,283,064,162.92
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额955,628,599.09-132,912,066.27-606,211,733.26-297,006,562.92
四、汇率变动对现金及现金等价物的影响5,149,356.7451,158,021.95669,731.6943,769,991.63
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额723,726,587.66170,633,857.2886,553,901.49229,179,576.31
加:期初现金及现金等价物余额1,477,600,220.011,306,966,362.731,306,966,362.731,306,966,362.73
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,201,326,807.671,477,600,220.011,393,520,264.221,536,145,939.04
补充资料:
净利润-1,107,463,116.83-754,349,946.71
资产减值准备-122,874,355.27-48,797,615.67
固定资产和投资性房地产折旧-803,234,363.56-382,009,632.69
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-803,234,363.56-382,009,632.69
无形资产摊销-113,539,469.6-56,714,912.31
长期待摊费用摊销-15,804,713.53-6,537,116.88
处置固定资产、无形资产和其他长期资产的损失--2,333,721.93-390,640.63
固定资产报废损失-8,709,957.24-3,607,305.75
公允价值变动损失-69,493,156.45-67,208,314.63
财务费用-139,337,388.45-70,667,557.63
投资损失-28,227,510.13-14,307,016.13
递延所得税--17,682,685.13--13,470,802.58
其中:递延所得税资产减少--17,682,685.13--13,470,802.58
存货的减少--78,327,395.16-166,007,371.21
经营性应收项目的减少--786,087,193.98--493,303,364.03
经营性应付项目的增加-597,684,896.15-217,474,490.74
其他-14,142,417.74-7,418,886.01
现金的期末余额-1,477,600,220.01-1,536,145,939.04
减:现金的期初余额-1,306,966,362.73-1,306,966,362.73
公告日期2025-04-302025-04-302024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑